The India malaria diagnostics market was valued at approximately USD 52.0 million in 2023 and is anticipated to grow steadily at a compound annual growth rate (CAGR) of 4.73% from 2024 to 2030. This upward trajectory is primarily driven by the increasing public health burden posed by malaria across different regions of India. According to data from the National Center for Vector Borne Diseases Control (NCVBDC), nearly 95% of the Indian population lives in areas where malaria is endemic, with a disproportionate 80% of malaria cases concentrated among just 20% of the population, particularly those residing in hilly and tribal regions.

Access to adequate healthcare facilities in these remote and often underserved areas remains a significant challenge, further exacerbating the malaria burden. The latest estimates from the World Health Organization (WHO) highlight that India contributes around 3% of the global malaria cases but is making notable progress by reducing malaria-related deaths, reflecting the government’s focused efforts to address this critical health issue.

The Indian government’s initiatives aimed at improving malaria diagnosis have played a pivotal role in shaping the market positively over recent years. For instance, the Government of India launched the National Strategic Plan (NSP) 2017-2022 in collaboration with WHO India, and is in the process of finalizing the plan for 2023-2027, which ambitiously aims to achieve zero malaria cases by 2027. These strategic plans present significant opportunities to enhance malaria surveillance, ensure the delivery of high-quality treatment, and expand diagnostic programs throughout the country.

In addition to policy support, technological advancements have emerged as a major catalyst driving market growth. Innovations like the Mobile-based Surveillance Quest using IT (MoSQuIT) system have automated malaria surveillance processes, while tools such as the National Malaria Case-Based Reporting App (MCBR) have improved real-time data collection and reporting. Furthermore, enhanced Rapid Diagnostic Tests (RDTs) now provide highly accurate and timely results, and cutting-edge devices like the Nanomal DNA analyzer, which leverages nanotechnology, have been introduced to advance diagnostics. The integration of artificial intelligence (AI) and geospatial technology has also significantly improved malaria surveillance and diagnosis in India, making detection more precise and responsive, ultimately helping to reduce disease transmission and improve health outcomes.

Key Market Trends & Insights:

• When analyzing the market by technology, the rapid diagnostic test (RDT) technology segment emerged as the leading contributor, capturing a significant revenue share of 53.8% in 2023. This dominance reflects the widespread adoption of RDTs due to their convenience, speed, and ability to provide quick and reliable results, which are critical for effective malaria diagnosis and timely treatment.

• In the category of molecular diagnostic tests, the modernized PCR (Polymerase Chain Reaction) molecular diagnostic tests segment held a dominant position in the market during 2023. The preference for PCR-based testing stems from its high sensitivity and accuracy in detecting malaria parasites, making it an essential tool for confirmatory diagnosis, especially in complex cases or regions aiming for malaria elimination.

Order a free sample PDF of the India Malaria Diagnostics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 52.0 Million

• 2030 Projected Market Size: USD 73.5 Million

• CAGR (2024-2030): 4.73%

Key Companies & Market Share Insights:

Some of the prominent companies operating in the India malaria diagnostics market include well-known names such as Abbott Laboratories, Bio-Rad Laboratories, Inc., Nikon India Pvt Ltd., along with several other key players. These organizations are strategically focused on expanding their customer base to secure a stronger competitive position within the industry. To achieve this goal, many leading companies are undertaking various strategic initiatives, including mergers and acquisitions as well as forming partnerships and collaborations with other major industry participants. These approaches help them enhance their market reach, diversify their product portfolios, and accelerate innovation.

Abbott Laboratories is a globally recognized healthcare company with a significant presence in India, particularly in the diagnostics segment. The company offers a range of advanced diagnostic products tailored for malaria detection, including rapid diagnostic tests (RDTs) and molecular diagnostic solutions. These cutting-edge tools help improve disease management and patient care by facilitating quick and accurate detection of malaria infections, which is crucial for timely treatment and control of the disease.

Similarly, BIOMÉRIEUX provides comprehensive in vitro diagnostics solutions with a strong focus on infectious diseases such as malaria. Operating in the Indian market, BIOMÉRIEUX offers a variety of diagnostic products that utilize advanced technologies including molecular biology techniques and immunoassays. These technologies enable faster and more precise detection of malaria, thereby supporting healthcare providers in delivering effective diagnosis and treatment.

Key Players

• Abbott.

• Siemens Healthineers AG

• Bio-Rad Laboratories, Inc.

• Beckman Coulter, Inc.

• Olympus Corporation

• ACCESS BIO.

• Premier Medical.

• MicroGene Diagnostic Systems (P) Ltd

• Nikon India Pvt Ltd

• BIOMÉRIEUX

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The India malaria diagnostics market is experiencing significant growth, driven by the increasing public health burden of malaria across various regions of the country. Approximately 95% of the Indian population resides in malaria-endemic areas, with a disproportionate concentration of cases in hilly and tribal regions. The Government of India's initiatives, such as the National Strategic Plan aiming for zero malaria cases by 2027, are positively influencing the market. Technological advancements, including the integration of AI and geospatial technologies, are enhancing the precision and efficiency of malaria diagnostics, further propelling market growth.